Fact CheckerSign in

NCT06701955Recruiting

Study of the Test-retest Reliability of the Neuropsychiatric Fluctuations Scale in Parkinson's Disease

Study of the Test-retest Reliability of the Neuropsychiatric Fluctuations Scale (EFN)

Source: ClinicalTrials.gov · Last updated 30 Sept 2026

Brief summary (registry, in English)

This study focuses on neuropsychiatric fluctuations (NPF) in Parkinson's disease. Due to the lack of specific assessment tools, we developed the Neuropsychological Fluctuations Scale (NFS), a 20-item questionnaire. Recent studies have confirmed its reliability, sensitivity, and validity. To finalize its validation, assessing its test-retest reliability is an essential next step.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
19 Nov 2024
Start date
30 Jan 2025
Primary completion date
1 Feb 2027
Lead sponsor
University Hospital, Grenoble
NCT number
NCT06701955

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 30 Jan 2025 to the primary completion date, 1 Feb 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Persons referred to in Articles L1121-5 to L1121-8 of the CSP (corresponds to all protected persons: pregnant women, parturients, breastfeeding mothers, persons deprived of liberty by judicial or administrative decision, persons receiving psychiatric care under Articles L. 3212-1 and L. 3213-1 who are not covered by the provisions of Article L. 1121-8, persons admitted to a health or social establishment for purposes other than research, minors, persons subject to a legal protection measure or unable to express their consent))

Other illness

  • Parkinsonian syndrome other than idiopathic Parkinson's disease
  • Dementia (MoCa \< 23)

Other

  • No antiparkinsonian treatment or treatment modified for less than one month
  • Subject in a period of exclusion from another interventional study.

Who the study is looking for

  • Age \> 30 and ≤ 75 years
  • Idiopathic Parkinson's disease (according to the criteria of the Movement Disorders Society)
  • Presence of motor fluctuations described by the patient, their relatives, or identified by the clinician
  • Stability of antiparkinsonian treatment for at least one month
  • Mastery of the French language
  • Able to give consent.
  • Affiliated to the social security system

Age in the registry: 30 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHUGA
Coordinator of this site? Confirm its status
GrenobleFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.